Geron Announces Publication in The Lancet of Results from the IMerge Phase 3 Clinical Trial Evaluating Imetelstat in Lower Risk MDS

Imetelstat is currently under regulatory review by the FDA and EMA for the treatment of transfusion-dependent anemia in adult patients with lower risk MDS


...

Related Keywords

Leipzig ,Sachsen ,Germany ,United States ,America ,Faye Feller ,Uwe Platzbecker ,Exchange Commission ,European Medicines Agency ,Drug Administration ,Department Of Hematology ,Geron Corporation Nasdaq ,Leipzig University Hospital ,European Union ,Linkedin ,Geron Corporation ,Executive Vice President ,Chief Medical ,Cellular Therapy ,Infectious Diseases ,North America ,Middle East ,Fast Track ,Nobel Prize Winning ,New Drug Application ,United States Food ,Prescription Drug User Fee Act ,Private Securities Litigation Reform Act ,Markets ,